Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000116763 | SCV000113908 | benign | not specified | 2014-06-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224571 | SCV000167775 | benign | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27535533, 21990111) |
Center for Pediatric Genomic Medicine, |
RCV000224571 | SCV000281471 | benign | not provided | 2016-05-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000226970 | SCV000290465 | benign | Neuronal ceroid lipofuscinosis | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000116763 | SCV000313279 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Counsyl | RCV000671702 | SCV000796703 | benign | Neuronal ceroid lipofuscinosis 8 | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311692 | SCV000846886 | benign | Inborn genetic diseases | 2016-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Broad Center for Mendelian Genomics, |
RCV001258280 | SCV001435205 | benign | Central core myopathy | criteria provided, single submitter | research | The homozygous p.Pro229Ala variant in CLN8 has been identified in 1 Mexican and 1 Argentinian individual with late infantile neuronal ceroid lipofuscinosis (PMID: 21990111). However, this variant is classified as benign for autosomal recessive neuronal ceroid lipofuscinosis because it has been identified in >5% of Latino chromosomes and 93 total homozygotes by ExAC (http://gnomad.broadinstitute.org/). | |
Athena Diagnostics | RCV000116763 | SCV001475016 | benign | not specified | 2020-03-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224571 | SCV005269642 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116763 | SCV000150739 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Mayo Clinic Laboratories, |
RCV000224571 | SCV000801856 | uncertain significance | not provided | 2015-12-15 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000671702 | SCV001456330 | benign | Neuronal ceroid lipofuscinosis 8 | 2020-09-16 | no assertion criteria provided | clinical testing |